Search results
Results from the WOW.Com Content Network
Puma has been a public company since 1986, listed on the Frankfurt Stock Exchange. French luxury group Kering (formerly known as PPR) holds 9.8%, Kering's largest shareholder Groupe Artemis owns 29% of the share capital. [47] Puma ranks as one of the top shoe brands with Adidas and Nike, [8] and employs more than 18,000 people worldwide. [5]
The stock of Puma SE (OTCPK:PMMAF, 30-year Financials) is believed to be significantly overvalued, according to GuruFocus Value calculation.
The stock of Puma SE (OTCPK:PUMSY, 30-year Financials) appears to be significantly overvalued, according to GuruFocus Value calculation.
The company has pumped a combined $13.28 billion into projects in America and the U.K. over the past year, helping drive a 50% boost in net income through the first nine months of 2024. —Michael ...
The following is a list of publicly traded companies having the greatest market capitalization, sometimes described as their "market value": [1]. Market capitalization is calculated by multiplying the share price on a selected day and the number of outstanding shares on that day.
In October 2012 the company raised around $138 million and its shares were listed on the New York Stock Exchange. [4] In 2016 Puma discovered that Robert Gadimian, senior director of regulatory affairs, had twice bought and sold stock based on his knowledge of unpublished clinical trial results; Puma quickly fired him after conducting an ...
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American market by capitalization.
Puma Biotech (PBYI) betters loss estimates in Q3. However, its only marketed drug, Nerlynx, disappoints with low sequential growth and as a result, shares take a hit.